159 results
8-K
EX-99.2
TRVN
Trevena Inc
1 Apr 24
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
6:00am
expectations, plans and prospects for the Company, including statements abo ut the Company’s strategy, future operations, clinical development and trials
8-K
EX-99.1
TRVN
Trevena Inc
1 Apr 24
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
6:00am
expectations, plans and prospects for the Company, including statements about the Company’s strategy, future operations, clinical development and trials
424B3
t85sg2d15z elvjcldpe
23 Jan 24
Prospectus supplement
4:15pm
8-K
EX-99.1
1p6mbs7i
28 Dec 23
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
2:09pm
8-K
EX-99.2
sdu0fn1
28 Dec 23
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
2:09pm
8-K
EX-99.1
88qja
14 Nov 23
Trevena Reports Third Quarter 2023 Results and Provides Business Update
12:00am
8-K
EX-99.2
p17jym hfi4q
2 Oct 23
Regulation FD Disclosure
7:05am
8-K
EX-99.3
n11qr6x ulea9jz
6 Sep 23
Regulation FD Disclosure
7:02am
8-K
EX-99.4
cszl0er0
6 Sep 23
Regulation FD Disclosure
7:02am
8-K
EX-99.1
wgcth 64rdz
14 Aug 23
Trevena Reports Second Quarter 2023 Results and Provides Business Update
7:05am
8-K
EX-99.1
sennw35xgs23ai2
20 Jul 23
Trevena, Inc. Appoints Mark Corrigan, M.D. to Board of Directors
7:05am
8-K
EX-99.1
x53haxl5vk
26 Jun 23
Trevena Announces New Topline OLINVYK Data Highlighting
7:05am
8-K
EX-99.1
8k6uup
30 May 23
Trevena Regains Compliance with Nasdaq Listing and Reaffirms Expected Near-Term Milestones
7:05am